The Institute for Research in Biomedicine was founded in 2000 with the goal of advancing the study of human immunology, with particular emphasis on the mechanisms of host defense.
The IRB benefits from a wide international network of collaborations.
In addition, the IRB provides teaching and training programs for graduate students from Swiss and foreign Universities.
New paper from the Molinari lab on ERLAD, a new degradative pathway for proteasome-resistant toxic polymers
The EMBO Journal published a work by Ilaria Fregno, Elisa Fasana et al. of Maurizio Molinari group, describing a new inducible, receptor-mediated, vesicular transport... Read more
Roger Geiger receives the prestigious ERC Starting grant to improve personalized adoptive T cell therapies for the treatment of cancer
Dr. Roger Geiger has been awarded the prestigious ERC Starting grant (1.4 million Euros) from the European Research Council. The aim of the granted project, named TIL-... Read more
New paper by the Perez Lab: IRB identifies the receptor of the virus responsible of the most common cause of permanent births defects, a study published in Cell
A collaborative effort between the Institute for Research in Biomedicine (IRB) affiliated to the Università della Svizzera italiana (USI), Genentech, USA and the... Read more
Rfx7: important transcription factor for natural killer cell-mediated immunity
A collaborative project between Swiss teams from the University and the Ludwig Center for Cancer Research of Lausanne, the ETH and the University of Zurich, and a team... Read more
The 2018 Louis-Jeantet Prize for Medicine conferred to Prof. Antonio Lanzavecchia
The Louis-Jeantet Foundation, during a ceremony hold on Wednesday April 25th at the Centre Médical Universitaire (CMU) in Geneva, conferred the 2018 Louis-Jeantet Prize... Read more
Università della Svizzera italiana and
Institute for Research in Biomedicine
for the position of
Director of the IRB